Alcohol Drinking as a Vital Sign
- Conditions
- Unhealthy DrinkingAlcohol Dependence
- Interventions
- Other: Training & Tech Support for Delivery of Alcohol Screening, Brief Intervention, and Referral To Treatment
- Registration Number
- NCT01135654
- Lead Sponsor
- Kaiser Permanente
- Brief Summary
The purpose of this study is to determine whether Alcohol Screening, Brief Intervention, and Referral to Specialty Chemical Dependency Treatment (as appropriate) by Non-Physicians versus Primary Care Providers (versus control group) is more likely to be implemented and more effective at reducing unsafe drinking.
- Detailed Description
This health services implementation study is a clustered, randomized trial. We propose to randomize primary care clinics to three arms-a control condition and two alternative modes of delivery of the NIAAA Clinician's Guide to Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) in primary care settings. In the Primary Care Physician or "PCP" arm, PCPs will be trained on the SBIRT protocols outlined in the NIAAA Clinicians' Guide and conduct brief intervention and referrals as needed. In the Non-Physician Provider or "NPP" arm, Medical Assistants will be trained to use the NIAAA screener and enter the results in the Electronic Medical Record, and NPPs (e.g., Behavioral Medicine Specialists, Clinical Nurses and Health Educators) will conduct brief intervention and referral activities. The SBIRT content, based on the NIAAA Guide, is the same in both the NPP and PCP arms; we compare delivery by the two types of providers and versus the control condition, in which providers and staff will not receive any training on SBIRT protocols. We examine implementation outcomes: rates of screening, brief intervention, follow-up screening and brief intervention, referral to Chemical Dependency treatment, and alcohol use disorders medication rates. We also include, as secondary analyses, an effectiveness study examining patient outcomes by study arm.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 639613
- Patients: All patients aged 18+ who receive primary care visits in the Kaiser Permanente clinics in Northern California.
- Patients younger than 18.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-Physician Provider Training & Tech Support for Delivery of Alcohol Screening, Brief Intervention, and Referral To Treatment - Primary Care Provider Training & Tech Support for Delivery of Alcohol Screening, Brief Intervention, and Referral To Treatment In clinics randomized to this arm, we will train (and provide technical assistance to) Primary Care providers to conduct Alcohol Screening, Brief Intervention, and Referral to Treatment.
- Primary Outcome Measures
Name Time Method Proportion of patients screened for alcohol One year We define the Screening Rate as the proportion of patients who receive the NIAAA brief screener (available in the Electronic Medical Record) from among all unique patients who have visits to the clinics in the relevant study arm in the year following the training of providers.
Proportion receiving Brief Intervention among those who screen positive to screener. One year. The proportion receiving Brief Intervention Rate is the proportion of patients who receive brief intervention from among all patients who have visits to the clinic in the one year period and screen positive on the NIAAA screener in the EMR.
Proportion of patients referred to treatment one year The treatment referral rate will be defined as the proportion of patients who receive referrals to Chemical Dependency treatment from among those who receive alcohol dependence diagnoses or whose screener indicates possible alcohol dependence.
- Secondary Outcome Measures
Name Time Method Changes in quantity of alcohol consumption - average weekly consumption one year We will examine changes in alcohol consumption measures (average weekly consumption at subsequent visits) for those who have return visits within the study observation period.
Trial Locations
- Locations (1)
Kaiser Permanente Northern California
🇺🇸Oakland, California, United States